This three-part series—Part 1 in the June issue covered patient confidentiality—reviews a few topics giving physicians concern during the COVID-19 pandemic. Maintaining Office Safety PATIENTS l You retain the right to refuse a...
Read MoreThis three-part series—Part 1 in the June issue covered patient confidentiality—reviews a few topics giving physicians concern during the COVID-19 pandemic. Maintaining Office Safety PATIENTS l You retain the right to refuse a...
Read MoreThis three-part series—Part 1 in the June issue covered patient confidentiality—reviews a few topics giving physicians concern during the COVID-19 pandemic. Maintaining Office Safety PATIENTS l You retain the right to refuse a...
Read MoreDETROIT – Treatment with hydroxychloroquine cut the death rate significantly in sick patients hospitalized with COVID-19 – and without heart-related side-effects, according to a new study published by Henry Ford Health System....
Read MoreTelemedicine has exploded in scope with the COVID-19 pandemic and will leave a lasting imprint on how medicine is practiced, so it is essential for physicians to understand its basic principles and the specific rules that govern...
Read MoreTelemedicine has exploded in scope with the COVID-19 pandemic and will leave a lasting imprint on how medicine is practiced, so it is essential for physicians to understand its basic principles and the specific rules that govern...
Read More
There’s a misconception that locum tenens doctors are constantly traveling across the country,...
Read MoreIn the past, we as physicians have not done a great job of advocacy, and we have largely been removed from policy discussions. The emergence of physician advocacy is a relatively new phenomenon. Why? … Read Full Article...
Read MoreTelemedicine has exploded in scope with the COVID-19 pandemic and will leave a lasting imprint on how medicine is practiced, so it is essential for physicians to understand its basic principles and the specific rules that govern...
Read MoreTelemedicine has exploded in scope with the COVID-19 pandemic and will leave a lasting imprint on how medicine is practiced, so it is essential for physicians to understand its basic principles and the specific rules that govern...
Read More
A new type of immunotherapy treatment for metastatic non-small cell lung cancer (NSCLC) is being...
Read More
Targeting tumor driver appears effective in half of NSCLC patients Treatment with the...
Read MoreNew research was virtually presented at AACR 2020, the American Association for Cancer Research Annual Meeting, from April 27-28. The features below highlight some of the studies that emerged from the conference. Cancer...
Read More
While it was previously thought that a subset of patients with limited metastatic disease could...
Read More
Updated findings from the phase 3 CASPIAN trial presented at the 2020 American Society of Clinical...
Read MoreIn the phase 2 ECOG-ACRIN EA5161 trial, a significant improvement in both progression-free and overall survival was observed from adding the checkpoint inhibitor nivolumab to chemotherapy (cisplatin/carboplatin with etoposide)...
Read More
MET-mutations and MET-amplifications are reported in 1-6% of patients with NSCLC. In the ongoing,...
Read More
To date, second-line chemotherapy is not the standard of care in patients with malignant pleural...
Read More
In an interim analysis of the DESTINY-Lung01 trial, trastuzumab deruxtecan (T-DXd) demonstrated...
Read More
In the phase 3 CCTG BR.34 trial, no additional effect on overall survival (OS) was observed by...
Read More
